- +91 8169745890
-
.png)
Anthem Biosciences Private Limited (Anthem) on June 13, 2006, was converted into a public company and renamed Anthem Biosciences Limited on December 10, 2024. Headquartered in Bangalore, Karnataka, the company operates as a Contract Research, Development, and Manufacturing Organization (CRDMO) with fully integrated services across drug discovery, development, and manufacturing.
The company functions primarily through two business segments: CRDMO Services and Specialty Ingredients. The CRDMO Services segment offers end-to-end solutions for New Chemical Entities (NCEs) and New Biological Entities (NBEs), covering target identification, preclinical development, and manufacturing for clinical trials and commercial-scale production. The Specialty Ingredients segment involves the production and sale of fermentation-based APIs, including probiotics, enzymes, and biosimilars.
Apply Now!
Started our journey back in 2008 with a goal of helping people grow their wealth as well as protect it. Catering to 200+ clients locally and internationally, Fine Investments is a one stop shop for all your financial investment needs.
Office No. 705, A-wing, AUM Avenue, MG Road, Near Ambaji Dham Mandir, Mulund West, Mumbai 400080
+91 8169745890
+91 8454941139
Copyright © Fine Investments. All rights reserved.
Risk Factors – Investments in Mutual Funds are subject to Market Risks. Read all scheme related documents carefully before investing. Mutual Fund Schemes do not assure or guarantee any returns. Past performances of any Mutual Fund Scheme may or may not be sustained in future. There is no guarantee that the investment objective of any suggested scheme shall be achieved. All existing and prospective investors are advised to check and evaluate the Exit loads and other cost structure (TER) applicable at the time of making the investment before finalizing on any investment decision for Mutual Funds schemes. We deal in Regular Plans only for Mutual Fund Schemes and earn a Trailing Commission on client investments. Disclosure For Commission earnings is made to clients at the time of investments.
AMFI Registered Mutual Fund Distributor – ARN-60554 | Date of initial registration ARN – 03-Dec-2010 | Current validity of ARN – 09-Apr-2028
Grievance Officer- Hitesh Shah | hitesh.fineinvestments@gmail.com
Important Links | Disclaimer | Disclosure | Privacy Policy | SID/SAI/KIM | Code of Conduct | SEBI Circulars | AMFI Risk Factors
